Importance Microhematuria (MH) is a common finding that often leads to further evaluation
for urinary tract cancers. There is ongoing debate about the extent to which patients with MH …

Introduction Disparities in survival for bladder and kidney cancer among the genders and
patients with varying insurance coverage have been identified. Microhematuria (MH), a …

Objective To identify patients who could safely avoid unnecessary radiation and
instrumentation after the detection of microscopic hematuria. Patients and Methods We …

Purpose: Patients presenting with microhematuria represent a heterogeneous population
with a broad spectrum of risk for genitourinary malignancy. Recognizing that patient-specific …

Purpose To report the incidence of urinary tract malignancies (UTM) and to compare the
diagnostic accuracy of cytology with cystoscopy, renal ultrasound (US) and computed …

Introduction The vast majority of patients who undergo a diagnostic evaluation for
microscopic hematuria (MH) do not have occult bladder cancer. Identifying patients with MH …

Objective To evaluate the age-stratified prevalence of upper tract urothelial malignancies
diagnosed on computed tomography urography in a large cohort of patients referred for …

Rationale Assessment of patients with asymptomatic microhematuria (aMh) has been a
challenge to urologists for decades. The aMh is a condition with a high prevalence in the …

Objective To assess the costs associated with incidental extraurinary findings on computed
tomography urogram (CTU) in patients with asymptomatic microscopic hematuria. Materials …

Aim: To evaluate the role of repeated urological evaluation after negative initial diagnostic
work-up of asymptomatic microhematuria (AMH) in low-risk patients. Patients and Methods …